The 32 references in paper I. Shirinsky V., V. Kozlov A., V. Shirinsky S., И. Ширинский В., В. Козлов А., В. Ширинский С. (2014) “ВЛИЯНИЕ СТАТИНОВ И БИОЛОГИЧЕСКИХ ПРЕПАРАТОВ НА АКТИВАЦИЮ МИТОГЕН-АКТИВИРОВАННЫХ ПРОТЕИНКИНАЗ У БОЛЬНЫХ РЕВМАТОИДНЫМ АРТРИТОМ // EFFECTS OF STATINS AND OTHER BIOLOGICAL PREPARATIONS UPON ACTIVATION OF MITOGEN-ACTIVATED PROTEIN KINASES IN PATIENTS WITH RHEUMATOID ARTHRITIS” / spz:neicon:mimmun:y:2009:i:1:p:71-78

1
Ширинский И.В., Малышева О.А., Ширинский В.С. Цитокиновая и антицитокиновая терапия ревматоидного артрита и рассеянного склероза // Медицинская иммунология. – 2001. – No 3. – С. 401-414.
(check this in PDF content)
2
Ширинский И.В., Желтова О.И., Соловьева Н.Ю., Ширинский В.С., Козлов В.А. Клиническая эффективность статинов при ревматоидном артрите – пилотное исследование // Медицинская иммунология. – 2007. – No 4-5. – С. 505-508.
(check this in PDF content)
3
Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., Healey L.A., Kaplan S.R., Liang M.H., Luthra H.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis // Arthritis Rheum. – 1988. – Vol. 31. – P. 315-324.
(check this in PDF content)
4
Boyum A. Isolation of leucocytes from human blood. A two-phase system for removal of red cells with methylcellulose as erythrocyte-aggregating agent // Scand. J. Clin. Lab. Invest., Suppl. – 1968. – Vol. 97. – P. 9-29.
(check this in PDF content)
5
Edwards C.K., 3rd. PEGylated recombinant human soluble tumour necrosis factor receptor type I (r-Hu-sTNF-RI): novel high affinity TNF receptor designed for chronic inflammatory diseases // Ann. Rheum. Dis. – 1999. – Vol. 58, Suppl. 1. – P. I73-181.
(check this in PDF content)
6
Fabris M., Tolusso B., Di Poi E., Tomietto P., Sacco S., Gremese E., Ferraccioli G. Mononuclear cell response to lipopolysaccharide in patients with rheumatoid arthritis: relationship with tristetraprolin expression // J. Rheumatol. – 2005. – Vol. 32. – P. 998-1005.
(check this in PDF content)
7
Forrest C.M., Harman G., McMillan R.B., Stoy N., Stone T.W., Darlington L.G. Modulation of cytokine release by purine receptors in patients with rheumatoid arthritis // Clin. Exp. Rheumatol. – 2005. – Vol. 23. – P. 89-92.
(check this in PDF content)
8
Gallin J., Snyderman R., Agents targeting transcription factors // Inflammation / ed. Fearon D.T., Barton F.H., Nathan C., Lippincot Williams & Wilkins, 1999. – P. 1159-1176.
(check this in PDF content)
9
Gao B., Calhoun K., Fang D. The proinflammatory cytokines IL-1beta and TNFalpha induce the expression of Synoviolin, an E3 ubiquitin ligase, in mouse synovial fibroblasts via the Erk1/2 - ETS1 pathway // Arthritis Res Ther. – 2006. – Vol. 8. – P. R172.
(check this in PDF content)
10
Greenwood J., Steinman L., Zamvil S.S. Statin therapy and autoimmune disease: from protein prenylation to immunomodulation // Nat. Rev. Immunol. – 2006. – Vol. 6. – P. 358-370.
(check this in PDF content)
11
Kanda H., Hamasaki K., Kubo K., Tateishi S., Yonezumi A., Kanda Y., Yamamoto K., Mimura T. Antiinflammatory effect of simvastatin in patients with rheumatoid arthritis // J. Rheumatol. – 2002. – Vol. 29. – P. 2024-2026.
(check this in PDF content)
12
Kinne R.W., Brauer R., Stuhlmuller B., Palombo-Kinne E., Burmester G.R. Macrophages in rheumatoid arthritis // Arthritis Res. – 2000. – Vol. 2. – P. 189-202.
(check this in PDF content)
13
Lazzerini P.E., Lorenzini S., Selvi E., Capecchi P.L., Chindamo D., Bisogno S., Ghittoni R., Natale M.R., Caporali F., Giuntini S., Marcolongo R., Galeazzi M., Laghi-Pasini F. Simvastatin inhibits cytokine production and nuclear factor-kB activation in interleukin 1beta-stimulated synoviocytes from rheumatoid arthritis patients // Clin. Exp. Rheumatol. – 2007. – Vol. 25. – P. 696 - 700.
(check this in PDF content)
14
Li M., Liu Y., Dutt P., Fanburg B.L., Toksoz D. Inhibition of serotonin-induced mitogenesis, migration, and ERK MAPK nuclear translocation in vascular smooth muscle cells by atorvastatin // Am J Physiol Lung Cell Mol Physiol. – 2007. – Vol. 293. – P. L463-471.
(check this in PDF content)
15
Lim L., Manser E., Leung T., Hall C. Regulation of phosphorylation pathways by p21 GTPases. The p21 Ras-related Rho subfamily and its role in phosphorylation signalling pathways // Eur. J. Biochem. – 1996. – Vol. 242. – P. 171-185.
(check this in PDF content)
16
Liote F., Boval-Boizard B., Weill D., Kuntz D., Wautier J.L. Blood monocyte activation in rheumatoid arthritis: increased monocyte adhesiveness, integrin expression, and cytokine release // Clin. Exp. Immunol. – 1996. – Vol. 106. – P. 13-19.
(check this in PDF content)
17
Loetscher H., Gentz R., Zulauf M., Lustig A., Tabuchi H., Schlaeger E.J., Brockhaus M., Gallati H., Manneberg M., Lesslauer W. Recombinant 55-kDa tumor necrosis factor (TNF) receptor. Stoichiometry of binding to TNF alpha and TNF beta and inhibition of TNF activity // J. Biol. Chem. – 1991. – Vol. 266. – P. 18324-18329.
(check this in PDF content)
18
McCarey D.W., McInnes I.B., Madhok R., Hampson R., Scherbakov O., Ford I., Capell H.A., Sattar N. Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebocontrolled trial // Lancet. – 2004. – Vol. 363. – P. 2015-2021.
(check this in PDF content)
19
Melchert R.B., Liu H., Granberry M.C., Kennedy R.H. Lovastatin inhibits phenylephrineinduced ERK activation and growth of cardiac myocytes // Cardiovasc Toxicol. – 2001. – Vol. 1. – P. 237-252.
(check this in PDF content)
20
Montag D.T. Successful development of a flow cytometric assay to analyze cytokine-induced phosphorylation pathways [CIPP] within peripheral blood leukocytes. Dissertation. Pittsburgh. – 2003. – P. 123.
(check this in PDF content)
21
Rossa C., Ehmann K., Liu M., Patil C., Kirkwood K.L. MKK3/6-p38 MAPK signaling is required for IL-1beta and TNF-alpha-induced RANKL expression in bone marrow stromal cells // J. Interferon Cytokine Res. – 2006. – Vol. 26. – P. 719-729.
(check this in PDF content)
22
Rossol M., Kaltenhauser S., Scholz R., Hantzschel H., Hauschildt S., Wagner U. The contactmediated response of peripheral-blood monocytes to preactivated T cells is suppressed by serum factors in rheumatoid arthritis // Arthritis Res Ther. – 2005. – Vol. 7. – P. R1189-1199.
(check this in PDF content)
23
Scallon B.J., Trinh H., Nedelman M., Brennan F.M., Feldmann M., Ghrayeb J. Functional comparisons of different tumour necrosis factor receptor / IgG fusion proteins // Cytokine. – 1995. – Vol. 7. – P.759-770.
(check this in PDF content)
24
Schett G., Zwerina J., Firestein G. The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis // Ann. Rheum. Dis.2008. – Vol. 67. – P. 909-916.
(check this in PDF content)
25
Senokuchi T., Matsumura T., Sakai M., Yano M., Taguchi T., Matsuo T., Sonoda K., Kukidome D., Imoto K., Nishikawa T., KimMitsuyama S., Takuwa Y., Araki E. Statins suppress oxidized low density lipoprotein-induced macrophage proliferation by inactivation of the small G protein-p38 MAPK pathway // J. Biol. Chem. – 2005. – Vol. 280 –. – P. 6627-6633.
(check this in PDF content)
26
Shinohara S., Hirohata S., Inoue T., Ito K. Phenotypic analysis of peripheral blood monocytes isolated from patients with rheumatoid arthritis // J. Rheumatol. – 1992. – Vol. 19. – P.211-215.
(check this in PDF content)
27
Stuhlmuller B., Ungethum U., Scholze S., Martinez L., Backhaus M., Kraetsch H.G., Kinne R.W., Burmester G.R. Identification of known and novel genes in activated monocytes from patients with rheumatoid arthritis // Arthritis Rheum. – 2000. – Vol. 43. – P. 775-790.
(check this in PDF content)
28
Suzuki M., Tetsuka T., Yoshida S., Watanabe N., Kobayashi M., Matsui N., Okamoto T. The role of p38 mitogen-activated protein kinase in IL-6 and IL-8 production from the TNFalpha- or IL-1beta-stimulated rheumatoid synovial fibroblasts // FEBS Lett. – 2000. – Vol. 465. – P. 23 - 27.
(check this in PDF content)
29
Toh M.L., Marotte H., Blond J.L., Jhumka U., Eljaafari A., Mougin B., Miossec P. Overexpression of synoviolin in peripheral blood and synoviocytes from rheumatoid arthritis patients and continued elevation in nonresponders to infliximab treatment // Arthritis Rheum. – 2006. – Vol. 54. – P. 2109 - 2118.
(check this in PDF content)
30
Turner N.A., O’Regan D.J., Ball S.G., Porter K.E. Simvastatin inhibits MMP-9 secretion from human saphenous vein smooth muscle cells by inhibiting the RhoA / ROCK pathway and reducing MMP-9 mRNA levels // FASEB J. – 2005. – Vol. 19. – P. 804-806.
(check this in PDF content)
31
Yamasaki S., Yagishita N., Tsuchimochi K., Nishioka K., Nakajima T. Rheumatoid arthritis as a hyper-endoplasmic-reticulum-associated degradation disease // Arthritis Res Ther. – 2005. – Vol. 7. – P. 181-186.
(check this in PDF content)
32
Yano M., Matsumura T., Senokuchi T., Ishii N., Murata Y., Taketa K., Motoshima H., Taguchi T., Sonoda K., Kukidome D., Takuwa Y., Kawada T., Brownlee M., Nishikawa T., Araki E. Statins activate peroxisome proliferator-activated receptor gamma
(check this in PDF content)